Document is current
Any future updates will be listed below
-
Authors
Dalhuisen, Iris https://orcid.org/0000-0002-7539-6498
Biemans, Tom
Vos, Cornelis F.
Hark, Sophie ter
van Oostrom, Iris
Spijker, Jan
Wijnen, Ben
van Exel, Eric
van Mierlo, Hans
de Waardt, Dieuwertje
Arns, Martijn
Tendolkar, Indira
Janzing, Joost
van Eijndhoven, Philip
-
Funding
Funding for this research was provided by:
ZonMw (852001925, 848016004)
- License Information
-
More Information
Article History
Received: 24 September 2024
Accepted: 21 March 2025
First Online: 23 April 2025
Declarations
:
: Dr. Arns holds equity in Sama Therapeutics; he has served as a consultant for Sama Therapeutics, Neumarker and Synaeda; and he is a named inventor on patents and intellectual property but receives no royalties. The other authors report no financial relationships with commercial interests.
